Showing results (281-290 of 297) with videos related to

Sort By:
Pageof 30
Oncology Letters|November 25, 2021
Establishment and characterization of prostate organoids from treatment-naïve patients with prostate cancerKatia Cheaito, Hisham F Bahmad, Ola Hadadeh, et al.
Journal of Gastrointestinal Oncology|January 16, 2025
Balancing anticancer therapy efficacy and safety in advanced hepatocellular carcinoma: a case reportMohamad Mourad, Layal Al Mahmasani, Noura Abbas, et al.
Scientific Reports|November 28, 2022
68Ga-PSMA PET/CT in early relapsed prostate cancer patients after radical therapyMohamad Haidar, Alain S Abi-Ghanem, Hicham Moukaddam, et al.
Frontiers in Public Health|December 30, 2021
Impact of the COVID-19 Pandemic on Cancer Researchers in 2020: A Qualitative Study of Events to Inform Mitigation StrategiesLouis Fox, Katharina Beyer, Elke Rammant, et al.
Radiation Oncology (London, England)|September 9, 2017
Nadir PSA is a strong predictor of treatment outcome in intermediate and high risk localized prostate cancer patients treated by definitive external beam radiotherapy and androgen deprivationFady B Geara, Muhammad Bulbul, Raja B Khauli, et al.
Gene|April 17, 2023
Frequency and mutational spectrum of PIK3CA gene mutations in breast cancer patients: Largest and first report from LebanonLama N Hamadeh, Lama Farhat, Lamia Hilal, et al.
Pharmacological Reports : PR|November 17, 2024
ONC206, an imipridone derivative, demonstrates anti-colorectal cancer activity against stem/progenitor cells in 3D cell cultures and in patient-derived organoidsAlissar Monzer, Fatima Ghamlouche, Kevork Wakimian, et al.
JCO Global Oncology|March 14, 2024
Discordance in Recommendation Between Next-Generation Sequencing Test Reports and Molecular Tumor Boards in IndiaAju Mathew, Sissmol Davis, Jeffrey Mathew Boby, et al.
Future Oncology (London, England)|July 6, 2022
The first Middle East and North Africa expert consensus recommendations for the management of advanced colorectal cancerHampig R Kourie, Fahad Ibnshamsah, Joseph Zouein, et al.
The Oncologist|March 18, 2015
BRCA1 and BRCA2 mutations in ethnic Lebanese Arab women with high hereditary risk breast cancerNagi S El Saghir, Nathalie K Zgheib, Hussein A Assi, et al.
Pageof 30